Such capability is not common in academia because it does not involve breakthrough or discovery research but is an essential aspect of increasing the “D” in R & D.

Given NRL’s close association with and expertise in regulatory affairs of IVDs; our assay development capabilities and our assay evaluation capacity; we are well situated to expedite the translation of research into commercially ready products and services. While our specialist and historic background is in blood-borne infectious disease diagnostic testing, our skills and expertise can be applied to other infections and indeed outside infectious diseases.

We have mature skills in regulatory affairs from many years of working with the TGA, well-developed quality systems; expert knowledge in diagnostics and laboratory medicine; and in the provision of regulatory support. Our partnerships and collaborations with QC and device manufacturers and other commercial/ pharma partners extend globally & strengthens the relationships and expertise we bring to the table

Page last updated: 8 July 2022